BioVex
Thousand Oaks, US · 5 known investors
Amgen is a biopharmaceutical company that develops and manufactures therapeutics targeting oncology, cardiovascular disease, inflammation, bone health, neuroscience, and other serious illnesses. The company operates globally with manufacturing facilities across the United States, Europe, and Asia, serving patients and healthcare providers worldwide.
Founders & leadership
WK
William K. Bowes
GB
George B. RathmannFirst CEO
Investors · 5
In the news
- Former BioVex CEO Who Sold to Amgen for $1 Billion Raises $30 Million for Replimune - BioSpacebiospace.com · 2015
- Amgen Raises Presence in Massachusetts With BioVex Buy, Boosts Hiring - BioSpacebiospace.com · 2011
- BioVex Raises $40 Million In First Close Of Series F Financing - BioSpacebiospace.com · 2009
- After Pulling I.P.O., BioVex Gets Funding - The New York Timesdealbook.nytimes.com · 2007
- BioVex Raises $22 Million in First Close of Series E Financing - BioSpacebiospace.com · 2007
- BioVex raises $22M for ongoing cancer trial | Fierce Biotechfiercebiotech.com · 2007